Amal Therapeutics Competitors and Similar CompaniesClear all
Alpha Tau Medical's competitors and similar companies include NKGen Biotech, Zymeworks and Gossamer Bio.
 Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date 2016 | Founding Date 2017 | Founding Date 2003 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Santa Ana, US HQ | Locations Vancouver, CA HQ Seattle, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 1041% increase | Employees 7316% increase | Employees 45519% increase | Employees 11820% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 973.3 m | Valuation ($) 208 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income N/A | Net income ($44.3m) (FY, 2024) | Net income ($81.1m) (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 11m | Total funding raised $ 125.9m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
NKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company